2.055
전일 마감가:
$2.11
열려 있는:
$2.12
하루 거래량:
494.27K
Relative Volume:
0.58
시가총액:
$145.61M
수익:
-
순이익/손실:
$-117.50M
주가수익비율:
-0.8563
EPS:
-2.4
순현금흐름:
$-114.31M
1주 성능:
+9.89%
1개월 성능:
+8.16%
6개월 성능:
+13.54%
1년 성능:
-14.02%
엔카르타 Stock (NKTX) Company Profile
명칭
Nkarta Inc
전화
(925) 407-1049
주소
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
NKTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
NKTX
Nkarta Inc
|
2.05 | 149.87M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.46 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
795.06 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.82 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
800.58 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
338.20 | 35.45B | 4.98B | 69.59M | 525.67M | 0.5197 |
엔카르타 Stock (NKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | 개시 | Rodman & Renshaw | Buy |
| 2024-08-14 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-10 | 개시 | Canaccord Genuity | Buy |
| 2022-07-28 | 개시 | Needham | Buy |
| 2022-07-18 | 개시 | SVB Leerink | Outperform |
| 2022-03-11 | 개시 | Raymond James | Outperform |
| 2022-03-08 | 개시 | H.C. Wainwright | Buy |
| 2022-01-06 | 개시 | William Blair | Outperform |
| 2021-11-18 | 개시 | SMBC Nikko | Outperform |
| 2021-07-16 | 개시 | Oppenheimer | Outperform |
| 2020-08-04 | 개시 | Cowen | Outperform |
| 2020-08-04 | 개시 | Evercore ISI | Outperform |
| 2020-08-04 | 개시 | Mizuho | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
엔카르타 주식(NKTX)의 최신 뉴스
Can Nkarta Inc. stock double in next 5 yearsTrade Volume Summary & Accurate Buy Signal Notifications - ulpravda.ru
Is Nkarta Inc. stock attractive for passive investors2025 Major Catalysts & Precise Buy Zone Identification - ulpravda.ru
Is Nkarta Inc. stock affected by interest rate hikesWeekly Stock Recap & Expert Approved Trade Ideas - ulpravda.ru
The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals
Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Analysts’ Recent Ratings Updates for Nkarta (NKTX) - Defense World
Nkarta Shares Show Signs of Finding a Floor - AD HOC NEWS
How strong is Nkarta Inc. stock balance sheetJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - Улправда
Why Nkarta Inc. stock is favored by top institutions2025 Volume Leaders & Daily Technical Stock Forecast Reports - Улправда
Portfolio Recap: Is Nkarta Inc. stock attractive for growth ETFsJuly 2025 Action & Fast Gain Stock Tips - Улправда
Nkarta (NASDAQ:NKTX) Rating Increased to Hold at Wall Street Zen - Defense World
Is Nkarta Inc. stock a safe buy before earningsJuly 2025 Price Swings & Weekly Stock Breakout Alerts - DonanımHaber
Nkarta, Inc.(NasdaqGS: NKTX) dropped from NASDAQ Biotechnology Index - marketscreener.com
What analysts say about Nkarta Inc stockPortfolio Diversification Tips & High Profit Trading Alerts - earlytimes.in
Nkarta, Inc. $NKTX Shares Sold by AWM Investment Company Inc. - Defense World
This trade activity should not be overlooked: Nkarta Inc (NKTX) - setenews.com
VIX Spike: Why analysts upgrade STVN stockWeekly Market Report & Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ
Nkarta (NASDAQ:NKTX) Downgraded by Wall Street Zen to Sell - MarketBeat
Nkarta Inc (NKTX) Performance and Fundamentals Dashboard tells a completely different story - setenews.com
We Think Nkarta (NASDAQ:NKTX) Needs To Drive Business Growth Carefully - Yahoo Finance
Why Nkarta Inc. stock remains undervaluedBond Market & Weekly Return Optimization Alerts - Newser
Nkarta to Participate in Evercore Healthcare Conference - The Manila Times
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Nkarta (NASDAQ:NKTX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
It is Poised to be a Bull Market for Nkarta Inc (NKTX) - setenews.com
Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha
How interest rate cuts could boost Nkarta Inc. stockMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
Why Nkarta Inc. stock appeals to dividend seekers2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Using Python tools to backtest Nkarta Inc. strategiesWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com
Will Nkarta Inc. stock split again soonJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com
How Nkarta Inc. stock benefits from strong dollarOil Prices & Reliable Trade Execution Plans - newser.com
A better buy-in window may exist right now for Nkarta Inc (NKTX) - setenews.com
What momentum indicators show for Nkarta Inc. stockTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Is it time to cut losses on Nkarta Inc.Product Launch & Comprehensive Market Scan Reports - newser.com
Will Nkarta Inc. stock deliver strong dividend growthSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Nkarta, Inc.Common Stock (NQ: NKTX - Markets Financial Content
Will Nkarta Inc. stock sustain high P E ratiosJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Nkarta reports Q3 EPS (29c), consensus (30c) - MSN
엔카르타 (NKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엔카르타 주식 (NKTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shook David | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
8,638 |
19,004 |
190,955 |
| Levin Alyssa | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
5,838 |
12,844 |
102,662 |
| Brandenberger Ralph | Chief Technical Officer |
Jan 15 '25 |
Sale |
2.20 |
7,447 |
16,383 |
124,796 |
| HASTINGS PAUL J | Chief Executive Officer |
Jan 15 '25 |
Sale |
2.20 |
17,378 |
38,232 |
319,859 |
| Hager Alicia J. | Chief Legal Officer |
Jan 15 '25 |
Sale |
2.20 |
9,584 |
21,085 |
146,735 |
자본화:
|
볼륨(24시간):